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ABSTRACT
Objectives: To compare the female sexual function index and sexual function of their partners between groups of pregnant 
and non-pregnant Turkish women.
Material and methods: This was a cross-sectional study of 321 women, including 252 healthy pregnant and 69 healthy 
nonpregnant women. Assessment of female sexual function index (FSFI), ARIZONA scores of their partners were compared 
in relation to some of the sociodemographic characteristics and pregnancy trimesters.
Results: Comparison of the groups revealed a significantly higher FSFI score in the non-pregnant group whereas the ARI-
ZONA score was significantly higher in the pregnant group (p < 0.001). Age, gravidity, parity and smoking rate adjusted 
mean differences of scores remained statistically significant (p < 0.001). Higher ARIZONA (> 11) score rate was significantly 
higher in pregnant groups (55.6% vs 23.2%, p < 0.001). Pregnancy was a risk factor for high ARIZONA score [OR: 4.1 (95% 
CI 2.2–7.6, p < 0.001)]. Lower FSFI score rate was significantly higher in the pregnant group (26.4% vs 69.4%, p < 0.001). 
Pregnancy was a risk factor for low FSFI score [OR: 6.4 (95% CI 3.5–11.7, p < 0.001)]. 
Conclusions: Both female sexual function index and ARIZONA scores of their partners were found to be significantly dif-
ferent between groups of pregnant and nonpregnant Turkish women which indicated altered sexual function of couples 
during pregnancy.
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INTRODUCTION
The female sexual response cycle is divided into four 
stages, including desire, arousal (excitement), orgasm, 
and dissolution [1]. Regarding these stages, women may 
experience different forms of sexual dysfunction such as 
lack of sexual desire, aroused arousal, and inaccessibility 
to orgasm and pain during sexual activity [1]. It is a multi-
factorial and underestimated problem with a prevalence 
of 20–50% in general [2]. Cayan et al. [3] evaluated women 
aged 18–65 years and found that the prevalence of sexual 
dysfunction in Turkish women was 46.9%. In literature, 
a significant decrease in sexual activities has been shown 
during pregnancy with increased gestational weeks [4]. The 
reasons suggested by this decline in sexual activity during 
pregnancy are physical discomfort, fear of harm to the baby, 
loss of interest, physical oddity, painful coitus, and lack of 
perceived attraction [5]. On the other hand in a previous 
study from Turkey, it was shown that The FSFI total scores 
were not significantly different between the pregnant and 
nonpregnant women. The study showed significant correla-
tions between the total testosterone and androstenedione 
levels and sexual function [6]. The sexual function of male 
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partners has been assessed by the ARIZONA scoring ques-
tionnaire, the reliability and validity of the ARIZONA scoring 
in the Turkish language were displayed by Soykan et al. [7]. 
The Turkish version of the ASEX-Female was shown to have 
good validity and reliability with good internal consistency 
(Cronbach’s alpha = 0.89). The correlation coefficient was 
0.53 for the validity analysis and the cutoff point was 11 for 
the ROC analysis, which is highly discriminative in terms of 
validity criteria.
Female sexual dysfunction (FSD) is thought to be 
a public health problem affecting couples’ quality of life. 
Pregnancy is a special time that involves physical, psycho-
logical and hormonal changes that affect women’s sexual 
lives. However, sexual changes during pregnancy and their 
relationship to their partners’ sexual quality require further 
investigation. 
Therefore, the aim of this study was to compare the 




This was a cross-sectional study of 321 women, including 
252 healthy pregnant and 69 healthy nonpregnant Turkish 
women. Female sexual function index (FSFI) and ARIZONA 
score of their partners were compared in relation to some 
of the sociodemographic characteristics that were assessed 
at the Department of Obstetrics and Gynecology in Kartal 
Training and Research Hospital Obstetrics and Gynecol-
ogy Clinics and Burhaniye State Hospital between February 
2018 and April 2019. The study was conducted with sexually 
active participants aged 18-41 (married and reported hav-
ing had sexual intercourse during the previous 4 weeks). 
The main exclusion criterion is the exclusion of pregnant 
women with abnormal continuing pregnancies, including 
the risk of miscarriage, preterm labor, and hypertensive 
disorder. Pregnant women were informed about pregnancy 
sexuality in the pregnancy education outpatient clinic in 
the same hospital and their questions were answered by 
a midwife. They were informed that sexual intercourse is 
safe during pregnancy, except in cases of pain, cramping, 
unexplained vaginal bleeding, early cervical dilatation, and 
early membrane rupture. Patient information forms and 
self-reported questionnaires were given to the patients who 
wanted to participate.
Design
This is a cross-sectional observational study in which the 
author collected data over a period of 15 months. Partici-
pants filled out self-reported questionnaires, including the 
Female Sexual Function Index (FSFI), and questions about 
their sociodemographic data and the ARIZONA survey was 
completed by the male partner of each female participant. 
Answers of the questionnaire on sociodemographic data 
were obtained regarding educational background, occu-
pational status, income, medical history and gravity, parity, 
abortion, vaginal births, and cesarean section. Education 
was classified as years 8 years (primary and secondary) and 
more than 8 years (high school and university). All par-
ticipants were married. Ethical approval was given by the 
Kartal Education and Research Hospital of Health Sciences 
University.
Main Outcome Measures
Sexual function was measured by FSFI, a 19-item self-ad-
ministered questionnaire that assessed sexual function with 
six domains over the past four weeks: desire, arousal, lubrica-
tion, orgasm, satisfaction, and pain. Rosen et al. [8] devel-
oped a self-reported questionnaire to assess female sexual 
function. Turkey’s FSF verification was done previously [9]. 
Questions 1, 2, 15 and 16 are scored between 1 and 5, while 
all other questions are scored between 0 and 5. The total 
score of each area obtained from the related questions is 
multiplied by the coefficient factor (Tab. 1). The total score 
of all women with a total score below 25 were considered to 
have sexual dysfunction [10]. To assess sexual dysfunction 
in the male partner, we used the Arizona Sexual Experi-
ence Scale (ASEX), an approved five-item self-assessment 
scale that measures five major aspects of sexuality: 1) sex 
drive, 2) sexual arousal, 3) vaginal lubrication (in women) 
or penile erection. (males), 4) ability to reach orgasm and 
5) satisfaction with orgasm. Each item gets scores between 
1 and 6, total scores 5–30 and higher results indicate more 
sexual dysfunction. Total score > 11 was considered to be 
sexual dysfunction [11]. Pregnancy was grouped as the 
first (0–13 weeks), second (14–26), and third (27–40 weeks) 
trimesters.
Statistical Analysis
The statistical parameters were computed using the 
Statistical Package for the Social Sciences version 21.0 (SPSS 
Inc., Chicago, IL, USA). The continuous variables were ex-
Table 1. Coefficients for each item of FSFI scoring system
Domain Item number Coefficient
Desire 1, 2 0.6
Arousal 3, 4, 5, 6 0.3
Lubrication 7, 8, 9, 10 0.3
Orgasm 11, 12, 13 0.4
Satisfaction 14, 15, 16 0.4
Pain 17, 18, 19 0.4
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pressed as the mean ± standard deviation. The categorical 
variables were expressed as the number and percentage. The 
Mann-Whitney U test was used in the comparison between 
the averages of two groups. The Kruskal-Wallis test was used 
to compare more than two continuous variables. Adjusted 
means were compared by ANCOVA. Multivariate regression 
analysis was used to assess adjusted associations. Statistical 
significance was defined as p < 0.05. 
RESULTS
There was a significant difference between groups in 
terms of mean age of female partners (p < 0.05) however 
mean BMI, money income and mean age of male partners 
were similar (p > 0.05) (Tab. 2). Gravidity (0.5 vs 1.8, p < 0.001) 
and parity (0.4 vs 0.6, p = 0.028) were significantly different 
between the groups. No difference was determined between 
the two groups in terms of rates of the route of previous 
deliveries (p > 0.05). No difference was observed between 
the two groups in terms of systemic disorder (p > 0.05). 
Educational status was also similar between pregnant and 
nonpregnant groups and groups of women with and without 
FSFI < 25 (p > 0.05). The smoking rate was significantly 
higher in the non-pregnant group (17.4% vs 8.3%, p = 0.028). 
Adjusted and unadjusted means of ARIZONA and FSFI scores 
were shown in Table 2. A comparison of the groups revealed 
a significantly higher FSFI score in the non-pregnant group 
whereas the ARIZONA score was significantly higher in the 
pregnant group (p < 0.001) (Tab. 3). Age, gravidity, parity and 
smoking rate adjusted mean of scores remained statistically 
significant (p < 0.001). Higher ARIZONA (> 11) score rate was 
significantly higher in pregnant groups (55.6% vs 23.2%, 
p < 0.001). Pregnancy was a risk factor for high ARIZONA 
score [OR: 4.1 (95% CI 2.2–7.6, p < 0.001)]. Lower FSFI score 
rate was significantly higher in the pregnant group (26.4% 
vs 69.4%, p < 0.001). In multivariate regression analysis 
pregnancy was found to be significantly associated with 
FSFI score < 25 (beta coefficient = 0.321, p < 0.001) after 
adjustment for the age, gravidity and smoker rates. Pregnancy 
was a risk factor for low FSFI score [OR:6.4 (95% CI 3.5–11.7, 
p < 0.001)]. A comparison of scores in relation to the three 
trimesters revealed no statistically significant difference 
(p > 0.05) (Tab. 4).
DISCUSSION
In the current study, which was performed with a sample 
of pregnant women, we found that the male partner sexual 
dysfunction (ARIZONA > 11) rate was higher in the pregnant 
group (55.6% vs 23.2%, p < 0.001). Pregnancy was a risk factor 
for high ARIZONA score [OR: 4.1 (95% CI 2.2–7.6, p < 0.001)]. 
Lower FSFI score rate was significantly higher in the pregnant 
Table 2. Comparison of demographic characteristics of pregnant 
and non-pregnant women




Non-pregnant 69 28.4 6.01
Pregnant 252 26.6 5.06 0.013
BMI [kg/m2]
Non-pregnant 69 24.7 4.9
Pregnant 252 26.4 12.6 0.26
Income 
Non-pregnant 69 1.8 0.7
Pregnant 252 1.9 0.6 0.177
Age of partner 
[years]
Non-pregnant 69 31.8 6.8
Pregnant 252 30.7 5.3 0.235
Table 3. Comparison summary of adjusted and unadjusted mean score values of pregnant and non-pregnant women
Groups N Mean Std. Deviation p value
FSFI Total Score
Non-pregnant 69 27.4 4.7
Pregnant 252 18.5 9.8 < 0.001
Age, Gravidity, Smoker Rate 
Adjusted FSFI Total Score
Non-pregnant 69 27.5 1.3 (SE)
Pregnant 252 18.5 0.6 (SE) < 0.001
ARIZONA Total Score
Non-pregnant 69 9.2754 2.71642
Pregnant 252 12.1349 3.72106 < 0.001
Age, Gravidity, Smoker Rate 
Adjusted Arizona Total Score
Non-pregnant 69 9.4 0.5 (SE)
Pregnant 252 12.1 0.2 (SE) < 0.001
Table 4. Comparison summary of mean score values of among 
different trimesters of pregnancies





First 72 19.4 9.8
Second 96 19.4 8.9 0.141
Third 84 16.4 10.5
Total 252 18.4 9.8
ARIZONA 
Total Score
First 72 12.6 4.3
Second 96 11.9 3.6 0.446
Third 84 11.8 3.1
Total 252 12.1 3.7
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group (26.4% vs 69.4%, p < 0.001). Pregnancy was a risk factor 
for low FSFI score [OR: 6.4 (95% CI 3.5–11.7, p < 0.001)]. A com-
parison of scores in relation to the three trimesters revealed no 
statistically significant difference. In our literature search, we 
encountered several studies and reviews on this issue, in one of 
these reviews, one hundred thirty-five studies were systemati-
cally reviewed. Ninety-five of these studies were evaluated in 
more detail in a meta-analysis. The prevalence of female sexual 
dysfunction in premenopausal women was estimated to be 
40.9%. The prevalence rates of individual sexual disorders 
range from 20.6% (lubrication difficulties) to 28.2% (hypoac-
tive sexual desire disorder). The results show that female sexual 
dysfunction is a major public health problem affecting 41% of 
premenopausal women in the world [12]. On the other hand, 
there are also several studies on specific populations especially 
the pregnant women, Ninivaggio et al. evaluated the sexual 
function of 623 nulliparous pregnant women using FSFI in the 
first, second and early third trimesters [13]. Authors reported 
sexual dysfunction rates of 36.3% in the first trimester, 36.8% 
in the second trimester, and 57% in the third trimester, and 
reported that mean FSFI scores decreased as the pregnancy 
progressed. The higher rate was reported in another study, 
Seven et al. [14] assessed pregnant Turkish women, sexual 
dysfunction rate was 77.6% in their study. In another study 
on Turkish pregnant women, Eryilmaz et al. showed 81.5% 
of sexual dysfunction during pregnancy. In their study with 
238 Turkish pregnant women, significant relationships be-
tween changes were reported in sexual life during pregnancy 
and marriage duration, educational level, parity, and gravidity 
[15]. Consistently, Erol et al. [16] and Çorbacıoğlu et al. [17] 
conducted their studies on In Turkish pregnant women, both 
studies noted lower sexual function scores in women in the third 
trimester of their pregnancies compared with those in their 
first two trimesters of pregnancy. Pregnancy, especially in the 
third trimester, was found to have an impact on sexual health 
and decreased sexual function during pregnancy [16, 18]. 
No differences were determined among different pregnancy 
trimesters in terms of either score in our study, higher mean to-
tal FSFI scores were observed in the first and second trimester 
but the difference did not reach statistical significance (19.5, 
19.5 and 16.5 respectively).
Educational status was found to have a significant impact 
on sexual function, women having been trained for more 
than 8 years the low risk of sexual dysfunction compared to 
women who have been trained for 8 years or less [6]. Educa-
tional status was similar between pregnant and nonpregnant 
groups and groups of women with and without FSFI < 25 or 
with and without ARIZONA score > 11 (p > 0.05) in our study 
population. Based on knowledge about sexual dysfunction in 
the third trimester, postpartum sexual function was assessed 
in a study; breastfeeding and poor partnership quality have 
emerged as important risk factors for postpartum sexual 
dysfunction problems. Depressive symptoms with cesar-
ean section and high maternal education were correlated 
with dysfunctional problems in many sub-areas. The findings 
showed that women at risk for female sexual dysfunction 
were significantly different in terms of partnership quality, 
breastfeeding, mode of delivery, maternal education and 
depressive symptoms [19]. The pool of data showed us that, 
sexual function decreases during pregnancy and worsens 
as the pregnancy progresses. This process is influenced by 
many factors such as socio-cultural factors, age, parity, breast-
feeding, depression, fatigue, sexual inactivity during the first 
trimester, postnatal body image, re-conception concerns, 
and concomitant urinary tract infections. There was no clear 
evidence that there is a relationship between the mode of 
delivery and changes in sexual function. Authors of this re-
view pointed out that; sexual quality of life should be part of 
history due to possible sequelae of pregnancy and childbirth 
[20]. Symptoms of sexual dysfunction during pregnancy may 
have a negative impact on the quality of life of women and af-
fect couples’ relationships, therefore some interventions may 
be required, one thousand thirty-seven articles were taken 
into consideration in a previous review on this issue, four 
were selected for full-text reading, and two randomized trials 
(159 participants) were included. Based on this review, due 
to the heterogeneity between the studies, the results could 
not be combined. Based on the findings of this review, it is 
not possible to make a clear and conclusive recommendation 
on the effectiveness and safety of interventions used in the 
treatment of symptoms of sexual dysfunction in pregnancy 
[21]. Therefore preventive measure have great importance on 
this issue, for this reason, risk factors have been assessed in the 
literature to introduce some measures, in the cross-sectional 
study including 286 pregnant women, being a partner at 
an advanced age, a history of miscarriage, a history of previ-
ous health problems and a high level of anxiety were found 
to be negative factors affecting sexual function. The authors 
of this study suggested that health professionals should be 
aware of a number of risk factors that may contribute to 
sexual dysfunction in pregnant women [22]. In another study, 
sexually active 246 pregnant women were included in this 
cross-sectional controlled study and a total of 210 non-preg-
nant women were used as controls. Groups were compared in 
terms of age, gestational age, incontinence, body mass index 
and obstetric history. Mean total FSFI scores were significantly 
lower in pregnant women than in non-pregnant women. In 
addition, the rate of sexual dysfunction in pregnant women 
was significantly higher than in non-pregnant women. How-
ever, no significant difference was found in the rate of sexual 
dysfunction in pregnant women compared to trimesters. In 
addition, gravidity and parity showed negative effects on 
sexual functions. However, the number of abortions did not 
affect sexual function. These data show that pregnancy sig-
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nificantly reduces sexual function in women [23]. This study 
by Aydin et al. was conducted on Turkish women and consist-
ent with our results, pregnancy was found to be a risk factor 
for sexual dysfunction, no data regarding partner’s sexual 
function was presented in the above-mentioned study.
Obesity and excess weight are increasing worldwide 
and can jeopardize the sexual functions of women. A previ-
ous study aimed to compare the sexual functions of normal 
and overweight women during pregnancy. A cross-sectional 
study on 105 overweight and 118 normal weights pregnant 
women in the 2nd and 3rd pregnancy trimesters was con-
ducted. Female Sexual Function Index (FSFI) was used to as-
sess sexual function. It was found that, in the second trimester, 
the mean total FSFI scores were similar to those of overweight 
and normal-weight women. While in the third trimester, the 
total FSFI scores of overweight women were significantly 
lower than those of normal-weight women. In the third tri-
mester, the mean scores of overweight women in the areas 
of desire, arousal, lubrication, orgasm, and dyspareunia were 
significantly lower. The authors of this study concluded that 
overweight women in the third trimester of pregnancy had 
weaker sexual functions compared to normal-weight women 
[24]. No difference was determined between pregnant and 
nonpregnant groups and groups of women with and without 
FSFI < 25 (p > 0.05) or with and without ARIZONA score > 11.
Limitations of this study, it was a cross-sectional study 
and was not prospective, on the other hand, comparisons 
were made between different women, not with the same 
women before and after pregnancy and to the best of our 
knowledge, this is the first study, which assessed sexual 
function for both partners.
CONCLUSIONS
In conclusion, both female sexual function index and 
ARIZONA scores of their partners were found to be signifi-
cantly different between groups of pregnant and nonpreg-
nant Turkish women which indicated altered sexual function 
of couples during pregnancy.
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